BRPI0211993B8 - sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais - Google Patents

sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais

Info

Publication number
BRPI0211993B8
BRPI0211993B8 BRPI0211993A BR0211993A BRPI0211993B8 BR PI0211993 B8 BRPI0211993 B8 BR PI0211993B8 BR PI0211993 A BRPI0211993 A BR PI0211993A BR 0211993 A BR0211993 A BR 0211993A BR PI0211993 B8 BRPI0211993 B8 BR PI0211993B8
Authority
BR
Brazil
Prior art keywords
functional groups
therapeutic system
transdermal therapeutic
system based
polyacrylate
Prior art date
Application number
BRPI0211993A
Other languages
English (en)
Portuguese (pt)
Other versions
BRPI0211993B1 (pt
BR0211993A (pt
Inventor
Theobald Frank
Klein Robert-Peter
Hille Thomas
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7696570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0211993(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of BR0211993A publication Critical patent/BR0211993A/pt
Publication of BRPI0211993B1 publication Critical patent/BRPI0211993B1/pt
Publication of BRPI0211993B8 publication Critical patent/BRPI0211993B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
BRPI0211993A 2001-08-24 2002-08-13 sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais BRPI0211993B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141652A DE10141652B4 (de) 2001-08-24 2001-08-24 Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
PCT/EP2002/009057 WO2003017988A1 (de) 2001-08-24 2002-08-13 Transdermales therapeutisches system auf der basis von polyacrylat-haftklebern ohne funktionelle gruppen

Publications (3)

Publication Number Publication Date
BR0211993A BR0211993A (pt) 2004-09-28
BRPI0211993B1 BRPI0211993B1 (pt) 2017-04-11
BRPI0211993B8 true BRPI0211993B8 (pt) 2021-07-27

Family

ID=7696570

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211993A BRPI0211993B8 (pt) 2001-08-24 2002-08-13 sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais

Country Status (13)

Country Link
US (1) US20040241219A1 (OSRAM)
EP (1) EP1418895B1 (OSRAM)
JP (1) JP4393188B2 (OSRAM)
KR (1) KR100920599B1 (OSRAM)
CN (1) CN1239153C (OSRAM)
AU (1) AU2002327831B2 (OSRAM)
BR (1) BRPI0211993B8 (OSRAM)
CA (1) CA2455064C (OSRAM)
DE (1) DE10141652B4 (OSRAM)
ES (1) ES2397920T3 (OSRAM)
MX (1) MXPA04001677A (OSRAM)
WO (1) WO2003017988A1 (OSRAM)
ZA (1) ZA200400312B (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024157A2 (en) 2000-09-19 2002-03-28 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
MXPA06000852A (es) * 2003-07-24 2006-03-30 Smithkline Beecham Corp Peliculas que se disuelven oralmente.
WO2005099766A1 (ja) * 2004-04-13 2005-10-27 Saitama Daiichi Pharmaceutical Co., Ltd. 架橋型皮膚用粘着剤
CN1329022C (zh) * 2004-08-31 2007-08-01 贵州太和制药有限公司 亲水性生物粘附凝胶贴剂及其制备工艺
ES2362366T3 (es) * 2005-03-12 2011-07-04 Unilever N.V. Visnadina para el tratamiento del prurito cutáneo del cuero cabelludo.
CN1320005C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带烷烃基的丙烯酸酯的组合物
CN1320008C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带羧基基团的丙烯酸酯的组合物
CN1320006C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带酯基基团的丙烯酸酯的组合物
CN1326894C (zh) * 2005-03-24 2007-07-18 上海交通大学 包含酯基部分带烷氧基的丙烯酸酯的组合物
CN1320009C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带羟基基团的丙烯酸酯的组合物
DE102006050558B4 (de) 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US8962014B2 (en) 2009-12-22 2015-02-24 Acino Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
CN101967213A (zh) * 2010-09-29 2011-02-09 北京化工大学 低分子量带有羧基的聚丙烯酸酯丙烯酸酯的制备方法
ES2545094T3 (es) 2010-12-14 2015-09-08 Acino Ag Sistema terapéutico transdérmico para la administración de un principio activo
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung
DE102018130469A1 (de) 2018-11-30 2020-06-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Diffusionsbarriere
DE102019120403A1 (de) 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
CA2039586A1 (en) * 1990-05-02 1991-11-03 Marian R. Appelt Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
RU94028108A (ru) * 1991-11-26 1996-06-20 Рисерч Дивелопмент Фаундейшн (US) Трансплантант, способ восстановления функционирования нерва, способ замены кровеносного сосуда
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE59409873D1 (de) * 1993-04-20 2001-10-25 Hexal Ag Wirkstoffpflaster
AU7255394A (en) * 1993-07-08 1995-02-06 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
EP0661046B1 (en) * 1993-12-30 1998-09-30 Rotta Research B.V. Transdermal patch with isosorbide dinitrate as active ingredient
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
US5614210A (en) * 1995-03-31 1997-03-25 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of alfuzosin
SE504430C2 (sv) 1995-06-20 1997-02-10 Ericsson Telefon Ab L M Magasin
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
ATE288256T1 (de) * 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
EP1103260B1 (de) * 1999-11-29 2005-01-26 Novosis AG Transdermalsystem zur Abgabe von Clonidin
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
WO2002024157A2 (en) * 2000-09-19 2002-03-28 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems

Also Published As

Publication number Publication date
CN1545408A (zh) 2004-11-10
WO2003017988A1 (de) 2003-03-06
CN1239153C (zh) 2006-02-01
ES2397920T3 (es) 2013-03-12
MXPA04001677A (es) 2004-05-31
US20040241219A1 (en) 2004-12-02
EP1418895A1 (de) 2004-05-19
AU2002327831B2 (en) 2007-10-25
ZA200400312B (en) 2004-11-01
JP4393188B2 (ja) 2010-01-06
DE10141652B4 (de) 2011-04-07
HK1069533A1 (en) 2005-05-27
KR100920599B1 (ko) 2009-10-08
BRPI0211993B1 (pt) 2017-04-11
EP1418895B1 (de) 2012-12-19
CA2455064C (en) 2010-08-03
KR20040044477A (ko) 2004-05-28
BR0211993A (pt) 2004-09-28
DE10141652A1 (de) 2003-03-13
CA2455064A1 (en) 2003-03-06
JP2005503390A (ja) 2005-02-03

Similar Documents

Publication Publication Date Title
BRPI0211993B8 (pt) sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais
PT1009393E (pt) Sistema terapeutico transdermico com camada auto-adesiva tipo reservatorio e camada posterior unidireccionalmente elastica
BR0207955A (pt) Agente de emplastro
HUP0103715A2 (hu) Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal
MXPA04001676A (es) Sistema terapeutico transdermico con fentanilo o sustancias relacionadas.
ES2056319T3 (es) Medios de fijacion oclusiva para aparato de ostomia.
BR0300935A (pt) Métodos e sistemas para a autenticação de componentes em um sistema gráfico
BR9807099A (pt) Dilatador nasal medicado montado externamente
BR0212970A (pt) Artigo adesivo, sistema de contato com água, e, etiqueta
BR0015894A (pt) Cartão contendo imagem
BR9506470B8 (pt) Composição adesiva sensível à pressão e sistema de distribuição transdérmica de droga.
BR0301687A (pt) Bandagem adesiva tendo uma camada seletivamente colocada
BR9712806A (pt) Emplastro de matriz adesiva sensìvel à pressão para liberação transdérmica de sais de agentes farmacêuticos
BR9905923A (pt) Agente de liberação de elemento de transferência/transfusão e métodos do mesmo
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
TW200516128A (en) Pressure-sensitive adhesive tape
TW200621319A (en) Transdermal therapeutic system with an adhesive layer, method of siliconizing a backing layer of the system, and use of the backing layer
BRPI0507982A (pt) sistema e método para fornecer tratamento a um corpo
PT1284718E (pt) Sistema terapeutico transdermal oclusivo com uma camada de reforco nao oclusiva
BR0215366A (pt) Formulações transdérmicas adesivas de diclofenac sódico
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
DE59607885D1 (de) Adhäsives mittel auf wässriger basis
BRPI0410093B8 (pt) curativo do tipo de proteção contra ultravioleta
AR025896A1 (es) Sistema de aplicacion dermica o transdermica que contiene un carragenato iota y su procedimiento de preparacion
AU2003216645A1 (en) Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/04/2017, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/08/2002, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2683 DE 07-06-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.